Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione, DOXORUBICINA ACCORD HEALTHCARE ITALIA 2 mg/ml concentrato per soluzione per infusione
PITAC_ MaPEPi
Phase 2 small_molecule active
Quick answer
Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione, DOXORUBICINA ACCORD HEALTHCARE ITALIA 2 mg/ml concentrato per soluzione per infusione for Pleural carcinosis is a Phase 2 program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sana Biotechnology
- Indication
- Pleural carcinosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active